BioCentury
ARTICLE | Company News

Management tracks: Ultragenyx, Epizyme

September 17, 2018 10:10 PM UTC

Rare and ultra-rare disease company Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) appointed Wladimir Hogenhuis as COO. Previously, he was SVP and general manager, specialty franchise at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK).

Epizyme Inc. (NASDAQ:EPZM) said CBO Susan Graf will step down, effective Sept. 30. In connection with Graf's departure, the epigenetics company restructured its management and said COO Matthew Ros will become chief strategy and business officer. ...